Table 3 Outcomes and side effects
| Â | Budesonide N = 23 | Control N = 27 | Absolute risk reduction (95% CI) |
|---|---|---|---|
Hospitalization, n(%) | 8(35) | 9(33) | −2(−28 to 24) |
Discharge criteria before 180 min, n (%) | 10(44) | 12(44) | −0.9(−28.6 to 26.7) |
Side effects, n (%) | 8(35) | 9(33) | −2(−28 to 24) |
 Palpitation, n | 6 | 6 |  |
 Tremor, n | 5 | 3 |  |
 Headache, n | 2 | 2 |  |
 Dry mouth, n | 2 | 4 |  |